PneumoniaNCT03426813
Early Mobilization of Patients With Community-acquired Pneumonia
A study of Pneumonia, run by Regionshospital Nordjylland at 1 site in Denmark.
Trial summary
Pneumonia is a common health problem.This thesis may clarify whether early mobilization influence the time these patients are hospitalized, whether they are rehospitalized and whether it is possible to reduce the mortality rate. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Pneumonia
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 98 participants
- Where
- 1 siteDenmark
- Study dates
- Oct 2012to Dec 2013
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- patients with community-acquired pneumonia
Who cannot join
- dementia
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Is There an Effect of Early Mobilization of Patients With Community-acquired Pneumonia?
Pneumonia is a common health problem.This thesis may clarify whether early mobilization influence the time these patients are hospitalized, whether they are rehospitalized and whether it is possible to reduce the mortality rate.
Read the detailed description
Pneumonia is a common health problem. More than 100,000 Danes contract pneumonia every year, and around 15,000 of these are hospitalized. The main treatment is antibiotics. An American study indicates that patients who are mobilized early are hospitalized for a shorter period of time. The objective of the thesis is: to determine the effect of mobilization within 24 hours after hospitalization of patients with pneumonia. The result will be number of hospitalization days, rehospitalisation and mortality.
Patients with pneumonia hospitalized in the period 1 September 2012 - 28 February 2013 in the Medical Centre, lung unit 204B at Vendsyssel Hospital will be included in the project. Within the first 24 hours of hospitalization, they will be tested by a physiotherapist and mobilized.
There are significant costs associated with the treatment of patients with pneumonia - both economic costs and human costs. This thesis may clarify whether early mobilization influence the time these patients are hospitalized, whether they are rehospitalized and whether it is possible to reduce the mortality rate.
- Conditions
- Pneumonia
- Being tested
- Historical control group for early mobilization
- Keywords
- mobilization, physiotherapy, community-acquired pneumonia
- Medical subject headings
- Pneumonia, Community-Acquired Pneumonia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Historical control group for early mobilizationOther
| Study group | Role | What they receive |
|---|---|---|
| Early mobilization | Other | Historical control group for early mobilization Receives: Other: Historical control group for early mobilization |
What is being measured
The primary outcome is the main question the study is designed to answer.
The number of hospitalization days
Length of stay
Measured: 6 months
Secondary outcomes (1)
Number of rehospitalizations
Rehospitalizations
Measured: 6 months after 1st hospitalization
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Feb 2018
- Study startOct 2012
- Primary completionOct 2013
- Study completionDec 2013
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PneumoniaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 98 participants (actual)
Sponsor and investigators
- Lead sponsor
- Regionshospital Nordjylland
- Sponsor type
- Other government
- Collaborators
- Hvidovre University Hospital
- Responsible party
- Principal investigator, Dorte Melgaard Kristiansen, Regionshospital Nordjylland
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03426813
- Sponsor's protocol ID
- RHN_DMK_04
- Status last verified
- Feb 2018
- First submitted
- 20 Dec 2012
- Last updated
- 8 Feb 2018
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Feb 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Is There an Effect of Early Mobilization of Patients With Community-acquired Pneumonia?
- ClinicalTrials.gov ID
- NCT03426813
- Acronym / sponsor ID
- RHN_DMK_04
- Conditions
- Pneumonia
- Keywords
- mobilization, physiotherapy, community-acquired pneumonia
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 98 participants (actual)
- Lead sponsor
- Regionshospital NordjyllandOther government
- Collaborators
- Hvidovre University Hospital
- Study start
- Oct 2012
- Primary completion
- Oct 2013 (actual)
- Study completion
- Dec 2013 (actual)
- First posted
- 8 Feb 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Pneumonia is a common health problem.This thesis may clarify whether early mobilization influence the time these patients are hospitalized, whether they are rehospitalized and whether it is possible to reduce the mortality rate.
Detailed description
Pneumonia is a common health problem. More than 100,000 Danes contract pneumonia every year, and around 15,000 of these are hospitalized. The main treatment is antibiotics. An American study indicates that patients who are mobilized early are hospitalized for a shorter period of time. The objective of the thesis is: to determine the effect of mobilization within 24 hours after hospitalization of patients with pneumonia. The result will be number of hospitalization days, rehospitalisation and mortality.
Patients with pneumonia hospitalized in the period 1 September 2012 - 28 February 2013 in the Medical Centre, lung unit 204B at Vendsyssel Hospital will be included in the project. Within the first 24 hours of hospitalization, they will be tested by a physiotherapist and mobilized.
There are significant costs associated with the treatment of patients with pneumonia - both economic costs and human costs. This thesis may clarify whether early mobilization influence the time these patients are hospitalized, whether they are rehospitalized and whether it is possible to reduce the mortality rate.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Early mobilization | Other | Other: Historical control group for early mobilizationHistorical control group for early mobilization |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- patients with community-acquired pneumonia
Key exclusion criteria (1 listed)
- dementia
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Historical control group for early mobilization | Other | Early mobilization |
Primary outcome
The number of hospitalization days
Time frame: 6 months
Length of stay
1 secondary outcome
Number of rehospitalizations
Time frame: 6 months after 1st hospitalization
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Feb 2018.
Related trials for Pneumonia
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Not yet recruitingPhase 2/3
A Pivotal Safety and Immunogenicity GBS-NN/NN2 Vaccine Maternal Immunisation Trial
Streptococcus Agalactiae Infection, Neonatal Sepsis
Active, not recruitingPhase 1
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
COVID-19
Enrolling by invitation
Personalized Ventilator Settings for Patients on ECMO
Acute Respiratory Distress Syndrome (ARDS), Extracorporeal Membrane Oxygenation
Not yet recruiting
Expanded Diagnostic Strategy in Older Adults Hospitalized With Community-Acquired Acute Respiratory Infection
Acute Respiratory Infection
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study of Pneumonia, run by Regionshospital Nordjylland at 1 site in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The number of hospitalization days (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Feb 2018.